Stock OTLK OUTLOOK THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Outlook Therapeutics, Inc.

Equities

OTLK

US69012T3059

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
7.07 USD -2.08% Intraday chart for Outlook Therapeutics, Inc. -10.51% -10.28%
28/05 Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD MT
28/05 Outlook Therapeutics, Inc. Receives European Commission Marketing Authorization for LYTENAVA? (bvacizumab grapa) for the Treatment of Wet AMD CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
OUTLOOK THERAPEUTICS, INC.
Other Biotechnology & Medical Research
-2.08%-10.51%-10.28%-76.43%-85.27% 165M
Bearish
Neutral
Bearish
  1. Stock Market
  2. Equities
  3. OTLK Stock
  4. Charts Outlook Therapeutics, Inc.
  5. Relative Strength Chart